ABSTRACT
Tumour-host immune interactions lead to complex changes in the tumour microenvironment (TME), impacting progression, metastasis and response to therapy. While it is clear that cancer cells can have the capacity to alter immune landscapes, our understanding of this process is incomplete. Herein we show that endocytic trafficking at the plasma membrane, mediated by the small GTPase ARF6, enables melanoma cells to impose an immunosuppressive TME that accelerates tumour development. This ARF6-dependent TME is vulnerable to immune checkpoint blockade therapy (ICB) but in murine melanoma, loss of Arf6 causes resistance to ICB. Likewise, downregulation of ARF6 in patient tumours correlates with inferior overall survival after ICB. Mechanistically, these phenotypes are at least partially explained by ARF6-dependent recycling, which controls plasma membrane density of the interferon-gamma receptor. Collectively, our findings reveal the importance of endomembrane trafficking in outfitting tumour cells with the ability to shape their immune microenvironment and respond to immunotherapy.
Subject(s)
ADP-Ribosylation Factor 6 , ADP-Ribosylation Factors , Cell Membrane , Immune Checkpoint Inhibitors , Melanoma , Tumor Microenvironment , Tumor Microenvironment/immunology , Animals , Humans , Mice , ADP-Ribosylation Factors/metabolism , ADP-Ribosylation Factors/genetics , Immune Checkpoint Inhibitors/pharmacology , Immune Checkpoint Inhibitors/therapeutic use , Melanoma/genetics , Melanoma/drug therapy , Melanoma/metabolism , Melanoma/pathology , Melanoma/immunology , Cell Line, Tumor , Cell Membrane/metabolism , Interferon gamma Receptor , Receptors, Interferon/metabolism , Receptors, Interferon/genetics , Protein Transport , Melanoma, Experimental/immunology , Melanoma, Experimental/metabolism , Melanoma, Experimental/pathology , Melanoma, Experimental/genetics , Mice, Inbred C57BL , FemaleABSTRACT
Adaptive immune resistance (AIR) is a protective process used by cancer to escape elimination by CD8+ T cells. Inhibition of immune checkpoints PD-1 and CTLA-4 specifically target Interferon-gamma (IFNγ)-driven AIR. AIR begins at the plasma membrane where tumor cell-intrinsic cytokine signaling is initiated. Thus, plasma membrane remodeling by endomembrane trafficking could regulate AIR. Herein we report that the trafficking protein ADP-Ribosylation Factor 6 (ARF6) is critical for IFNγ-driven AIR. ARF6 prevents transport of the receptor to the lysosome, augmenting IFNγR expression, tumor intrinsic IFNγ signaling and downstream expression of immunosuppressive genes. In murine melanoma, loss of ARF6 causes resistance to immune checkpoint blockade (ICB). Likewise, low expression of ARF6 in patient tumors correlates with inferior outcomes with ICB. Our data provide new mechanistic insights into tumor immune escape, defined by ARF6-dependent AIR, and support that ARF6-dependent endomembrane trafficking of the IFNγ receptor influences outcomes of ICB.
ABSTRACT
Shark depredation is a complex social-ecological issue that affects a range of fisheries worldwide. Increasing concern about the impacts of shark depredation, and how it intersects with the broader context of fisheries management, has driven recent research in this area, especially in Australia and the United States. This review synthesises these recent advances and provides strategic guidance for researchers aiming to characterise the occurrence of depredation, identify the shark species responsible, and test deterrent and management approaches to reduce its impacts. Specifically, the review covers the application of social science approaches, as well as advances in video camera and genetic methods for identifying depredating species. The practicalities and considerations for testing magnetic, electrical, and acoustic deterrent devices are discussed in light of recent research. Key concepts for the management of shark depredation are reviewed, with recommendations made to guide future research and policy development. Specific management responses to address shark depredation are lacking, and this review emphasizes that a "silver bullet" approach for mitigating depredation does not yet exist. Rather, future efforts to manage shark depredation must rely on a diverse range of integrated approaches involving those in the fishery (fishers, scientists and fishery managers), social scientists, educators, and other stakeholders.
ABSTRACT
Melanoma has an unusual capacity to spread in early-stage disease, prompting aggressive clinical intervention in very thin primary tumors. Despite these proactive efforts, patients with low-risk, low-stage disease can still develop metastasis, indicating the presence of permissive cues for distant spread. Here, we show that constitutive activation of the small GTPase ARF6 (ARF6Q67L) is sufficient to accelerate metastasis in mice with BRAFV600E/Cdkn2aNULL melanoma at a similar incidence and severity to Pten loss, a major driver of PI3K activation and melanoma metastasis. ARF6Q67L promoted spontaneous metastasis from significantly smaller primary tumors than PTENNULL, implying an enhanced ability of ARF6-GTP to drive distant spread. ARF6 activation increased lung colonization from circulating melanoma cells, suggesting that the prometastatic function of ARF6 extends to late steps in metastasis. Unexpectedly, ARF6Q67L tumors showed upregulation of Pik3r1 expression, which encodes the p85 regulatory subunit of PI3K. Tumor cells expressing ARF6Q67L displayed increased PI3K protein levels and activity, enhanced PI3K distribution to cellular protrusions, and increased AKT activation in invadopodia. ARF6 is necessary and sufficient for activation of both PI3K and AKT, and PI3K and AKT are necessary for ARF6-mediated invasion. We provide evidence for aberrant ARF6 activation in human melanoma samples, which is associated with reduced survival. Our work reveals a previously unknown ARF6-PI3K-AKT proinvasive pathway, it demonstrates a critical role for ARF6 in multiple steps of the metastatic cascade, and it illuminates how melanoma cells can acquire an early metastatic phenotype in patients. SIGNIFICANCE: These findings reveal a prometastatic role for ARF6 independent of tumor growth, which may help explain how melanoma spreads distantly from thin, early-stage primary tumors.Graphical Abstract: http://cancerres.aacrjournals.org/content/canres/79/11/2892/F1.large.jpg.
Subject(s)
ADP-Ribosylation Factors/metabolism , Melanoma/pathology , Phosphatidylinositol 3-Kinases/metabolism , Skin Neoplasms/pathology , ADP-Ribosylation Factor 6 , ADP-Ribosylation Factors/genetics , Animals , Cyclin-Dependent Kinase Inhibitor p16/genetics , Guanosine Triphosphate/metabolism , Humans , Lung Neoplasms/secondary , Melanoma/metabolism , Melanoma, Experimental/metabolism , Melanoma, Experimental/pathology , Mice, Mutant Strains , Mice, SCID , Neoplasm Metastasis , PTEN Phosphohydrolase/genetics , Proto-Oncogene Proteins B-raf/genetics , Proto-Oncogene Proteins c-akt/metabolism , Skin Neoplasms/metabolismABSTRACT
Biological characteristics of Pentaceropsis recurvirostris, Paristiopterus gallipavo and Parazanclistius hutchinsi were determined from commercial gillnet samples from temperate south-western Australian coastal waters. Growth zones in otoliths, with more than a few such zones, were readily detectable only after the otoliths had been sectioned. Visual analyses and modelling of the trends in marginal increments on sectioned otoliths demonstrate that these opaque zones are formed annually. Maximum ages of 55, 36 and 49 years, derived for P. recurvirostris, P. gallipavo and P. hutchinsi, respectively, reflect relatively low mortalities. These longevities greatly exceed those estimated, using otoliths, for Pentaceros wheeleri and Pentaceros richardsoni, which belong to the other pentacerotid subfamily. These differences may be due to the counts of 'daily' growth zones in sectioned otoliths of P. wheeleri not representing the complete age range of that species and the zones detected in whole otoliths of P. richardsoni not constituting the complete range of annually-formed zones. Pentaceropsis recurvirostris, P. gallipavo and P. hutchinsi recruited into the fishery in the sampling area as 2-3 year-old fishes. Pentaceropsis recurvirostris and P. hutchinsi exhibited little or no subsequent growth throughout the remainder of their protracted life, whereas, P. gallipavo continued to grow for c. 5 years and then underwent little further growth. Spawning of P. recurvirostris and P. hutchinsi peaked in the austral winter and autumn, respectively, but in the austral spring and summer with P. gallipavo, which is more typical of temperate species. Although the females of P. gallipavo and P. hutchinsi were mature, this did not apply to a few P. recurvirostris, some of which were >20 years old, implying that any given female of this species does not always spawn every year. Ovarian mass greatly exceeded testis mass, indicative of pair spawning, which is consistent with field observations. In contrast to P. recurvirostris and P. hutchinsi, the sex ratio was heavily biased towards males and the spawning period longer in P. gallipavo, suggesting that selection pressures for spawning success were greater for this latter species.
Subject(s)
Longevity , Otolithic Membrane/growth & development , Perciformes/growth & development , Reproduction , Age Determination by Skeleton , Animals , Australia , Female , Fisheries , Male , Mortality , Ovary/growth & development , Sex Ratio , Sexual MaturationABSTRACT
This study has determined the extents and basis for variations in the composition of the prey ingested by the abundant species of a family highly adapted for ambush predation, i.e. Platycephalidae, in a region (south-western Australia) where that family is found in different habitats and environments. Dietary data were thus collected for Leviprora inops and Platycephalus laevigatus from seagrass in marine embayments and for Platycephalus westraliae from over sand in an estuary. These were then collated with those recorded previously for Platycephalus speculator from over sand and in seagrass in an estuary and for Platycephalus longispinis from over sand in coastal marine waters. While crustaceans and teleosts together dominated the diet of all five species, their percentage volumetric dietary contributions varied greatly, with those of crustaceans ranging from 7% for L. inops to 65% for P. speculator and those of teleosts ranging from 29% for P. longispinis to 91% for L. inops. For analyses, the data were separated into two sets. The first comprised the 17 dietary categories of invertebrates and all identified and unidentified teleosts collectively, while the second consisted of the 23 identified teleost families, both of which were subjected to permutational analysis of variance (PERMANOVA), analysis of similarities (ANOSIM) and a new (two-way) version of the RELATE procedure. The diets of three species changed seasonally, when using invertebrate dietary categories and teleosts collectively, but with only one species, when employing identified teleost families, probably reflecting a greater tendency for invertebrate than teleost prey abundance to change during the year. On the basis of dietary data for invertebrate taxa + teleosts collectively, the diets of three of the five species changed serially with body size, with a fourth species feeding, throughout life, predominantly on the carid Palaemonetes australis. Based on identified teleost families, the diets of the three species that fed predominantly on teleosts underwent serial size-related changes. Although L. inops and the co-occurring P. laevigatus both consume large volumes of teleosts, the former ingests larger, less demersal and more mobile prey, e.g. the labrids Haletta semifasciata and Neoodax balteatus, than the latter, e.g. the scorpaenid Gymnapistes marmoratus, reflecting the possession by L. inops of a far longer head and larger buccal cavity. Circumstantial evidence suggests that the large differences in the volumes of crustaceans and teleosts consumed by each platycephalid species are related to differences in the relative availability of these prey in the different habitats or environments of each species.
Subject(s)
Diet/veterinary , Ecosystem , Perciformes/physiology , Predatory Behavior , Animals , Australia , Bays , Body Size , Estuaries , Gastrointestinal Contents , SeasonsABSTRACT
Key biological characteristics of the harlequin fish Othos dentex, a representative of a monospecific genus of the Anthiinae (Serranidae), were determined from samples collected around reefs on the south coast of Western Australia. The females of this relatively long-lived species (maximum recorded age in this study = 37 years) attained only a slightly greater maximum total length and age than males and neither the length nor the age-frequency distributions showed a conspicuous sex-based bimodality. Furthermore, gonads from a wide size and age range of O. dentex were shown by histology, at several locations along their length, to always comprise exclusively either ovarian or testicular tissues. Thus, O. dentex is a gonochorist, a sexual pattern only previously recorded definitively for one other anthiine serranid, i.e. Epinephelides armatus, which also occurs in south-western Australia. Similar to E. armatus, O. dentex possesses 'solid' testes with a central sperm duct, thereby differing in structure from those typically found in serranids, in which there is a central membrane-bound 'ovarian' lumen and peripherally located sperm sinuses. The gonadal characteristics and sexual pattern of these two gonochoristic anthiines are not consistent with a recent proposal for the trends exhibited by the evolution of gonochorism and protogyny within the Serranidae. Othos dentex has indeterminate fecundity and a protracted spawning period (7 months) and, on the basis of underwater observations and a low gonado-somatic index (I(G)) for males, is a pair spawner, which is unusual for a gonochorist of a serranid or member of a related family. While the large spots on the lower half of the body of O. dentex are shown quantitatively to be similarly yellow in juveniles and adult females, they then become blue in males at maturity and this intensifies during the spawning period, when they presumably play an important role in agonistic interactions among males and courtship with females. The attainment of maturity and rapid growth by O. dentex early in life may reflect selection pressures to reduce predation mortality during that period. Total mortality in the population is moderately low during later life, implying that the current fishing pressure on O. dentex is relatively light.
Subject(s)
Bass/growth & development , Reproduction/physiology , Sexual Maturation , Aging/physiology , Animals , Bass/physiology , Body Size , Female , Gonads/growth & development , Male , Pigmentation , Sex Determination Processes , Western AustraliaABSTRACT
The glycoproteins secreted by Schistosoma mansoni cercariae and eggs play a key role in parasite transmission to and from the mammalian host. We used secreted preparations from these two life cycle stages to characterize the reactivity of sera from baboons exposed to normal and/or attenuated cercariae, in comparison with somatic antigen preparations and defined glycan epitopes. Periodate treatment of native antigens revealed that responses to the two secreted preparations were overwhelmingly directed against glycans rather than peptides. Considerable immunological cross-reactivity between glycans in the two preparations was inferred from a comparison of sera from infected-only and vaccinated-only animals, predominantly exposed to egg and cercarial secretions, respectively. In contrast, when somatic antigen preparations derived from adult worms or eggs were used to probe sera, a stronger antipeptide response was seen that accounted for up to 66% of maximum reactivity. Probing of sera with defined glycan structures confirmed the time course of responses and the presence of cross-reactive epitopes. In spite of the intense antiglycan response elicited in mice by administration of live eggs, no protection against a cercarial challenge was observed. Our data further support the hypothesis that antiglycan responses are a smokescreen with negligible protective potential.
Subject(s)
Antibodies, Helminth/immunology , Antibody Specificity/immunology , Papio/parasitology , Schistosoma mansoni/immunology , Schistosomiasis mansoni/immunology , Animals , Antibodies, Helminth/blood , Antigen-Antibody Reactions , Antigens, Helminth/immunology , Antigens, Surface/immunology , Enzyme-Linked Immunosorbent Assay , Epitopes/immunology , Female , Glycoproteins/immunology , Immune Sera/immunology , Immunoglobulin G/blood , Immunoglobulin G/immunology , Mice , Mice, Inbred C57BL , Polysaccharides/immunologyABSTRACT
The Prostate Cancer Risk Management Programme (PCRMP) launched in November 2002 provides guidelines for general practitioners (GPs) on age-specific prostate-specific antigen (PSA) cutoff levels in asymptomatic men. The impact of the PCRMP on GP referrals is unknown. This study investigates whether there was a change in the proportion of asymptomatic men with raised PSA levels (> or =3 ng ml(-1)) who were referred to urologists since the launch of the guidelines. Sixty-nine general practices in four areas of England and the main pathology laboratory in each area, which had participated in our previous research, were asked to provide data. Forty-eight practices (70%) provided retrospective data on urological referrals in men who had a PSA test taken in the periods 1 December 2001 to 31 May 2002 (pre-launch) and 1 December 2003 to 31 May 2004 (post-launch). Data on referrals were completed for 709 (79%) out of 898 and 1040 (90%) out of 1157 raised records pre- and post-launch, respectively. The percentage of men with raised PSA levels who were asymptomatic was similar in both time periods (19-20%) and the proportion referred to urologists according to the PCRMP guidelines did not increase significantly over time (24% pre-launch and 29% post-launch, P=0.42). The referral rate was lower than expected if the guidelines had been followed. The influence of the guidelines seems to have been low. At the time of data collection, 56% (112 out of 200) of GP partners reported that they were aware of receiving the PCRMP pack. To ensure future, effective implementation of guidelines requires evaluation.
Subject(s)
Family Practice , Practice Patterns, Physicians' , Prostatic Neoplasms/diagnosis , Referral and Consultation/trends , Urology , Aged , Aged, 80 and over , Early Diagnosis , England , Humans , Male , Middle Aged , National Health Programs , Practice Guidelines as Topic , Prostate-Specific Antigen/analysis , Risk Management/methodsABSTRACT
The feasibility of a population-based evaluation of screening for prostate cancer in men with a raised familial risk was investigated by studying reasons for non-participation and uptake rates according to postal recruitment and clinic contact. The levels of prostate-specific antigen (PSA) and the positive predictive values (PPV) for cancer in men referred with a raised PSA and in those biopsied were analysed. First-degree male relatives (FDRs) were identified through index cases (ICs): patients living in two regions of England and diagnosed with prostate cancer at age < or =65 years from 1998 to 2004. First-degree relatives were eligible if they were aged 45-69 years, living in the UK and had no prior diagnosis of prostate cancer. Postal recruitment was low (45 of 1687 ICs agreed to their FDR being contacted: 2.7%) but this was partly due to ICs not having eligible FDRs. A third of ICs in clinic had eligible FDRs and 49% (192 out of 389) agreed to their FDR(s) being contacted. Of 220 eligible FDRs who initially consented, 170 (77.3%) had a new PSA test taken and 32 (14.5%) provided a previous PSA result. Among the 170 PSA tests, 10% (17) were > or =4 ng ml(-1) and 13.5% (23) tests above the age-related cutoffs. In 21 men referred, five were diagnosed with prostate cancer (PPV 24%; 95% CI 8, 47). To study further the effects of screening, patients with a raised familial risk should be counselled in clinic about screening of relatives and data routinely recorded so that the effects of screening on high-risk groups can be studied.
Subject(s)
Mass Screening/standards , Prostate-Specific Antigen/blood , Prostatic Neoplasms/diagnosis , Age of Onset , Aged , Genetic Counseling , Genetic Predisposition to Disease , Humans , Male , Middle Aged , Pedigree , Predictive Value of Tests , Reference Values , Risk FactorsABSTRACT
The radiation-attenuated Schistosoma mansoni vaccine is highly effective in rodents and primates but has never been tested in humans, primarily for safety reasons. To strengthen its status as a paradigm for a human recombinant antigen vaccine, we have undertaken a small-scale vaccination and challenge experiment in chimpanzees (Pan troglodytes). Immunological, clinical, and parasitological parameters were measured in three animals after multiple vaccinations, together with three controls, during the acute and chronic stages of challenge infection up to chemotherapeutic cure. Vaccination induced a strong in vitro proliferative response and early gamma interferon production, but type 2 cytokines were dominant by the time of challenge. The controls showed little response to challenge infection before the acute stage of the disease, initiated by egg deposition. In contrast, the responses of vaccinated animals were muted throughout the challenge period. Vaccination also induced parasite-specific immunoglobulin M (IgM) and IgG, which reached high levels at the time of challenge, while in control animals levels did not rise markedly before egg deposition. The protective effects of vaccination were manifested as an amelioration of acute disease and overall morbidity, revealed by differences in gamma-glutamyl transferase level, leukocytosis, eosinophilia, and hematocrit. Moreover, vaccinated chimpanzees had a 46% lower level of circulating cathodic antigen and a 38% reduction in fecal egg output, compared to controls, during the chronic phase of infection.
Subject(s)
Antigens, Helminth/immunology , Schistosoma mansoni/immunology , Schistosomiasis mansoni/immunology , Schistosomiasis mansoni/prevention & control , Vaccines, Attenuated/immunology , Animals , Antibodies, Helminth/blood , Antigens, Helminth/blood , Cytokines/biosynthesis , Immunization Schedule , Lymphocyte Activation , Male , Pan troglodytes , Parasite Egg Count , Schistosoma mansoni/radiation effects , Schistosomiasis mansoni/parasitology , Th1 Cells/immunology , Th2 Cells/immunology , VaccinationABSTRACT
Multiple exposures of chimpanzees to the radiation-attenuated schistosome vaccine provoked a strong parasite-specific cellular and humoral immune response. Specific IgM and IgG were directed mainly against glycans on antigens released by cercariae; these were also cross-reactive with soluble antigens from larvae, adult worms, and eggs. Egg deposition was the major antigenic stimulus after challenge of vaccinated and control chimpanzees with normal parasites, eliciting strong antiglycan responses to egg secretions. Glycan epitopes recognized included LacdiNAc, fucosylated LacdiNAc, Lewis(X) (weakly), and those on keyhole limpet hemocyanin. Antibodies to peptide epitopes became prominent only during the chronic phase of infection, as glycan-specific IgM and IgG decreased. Because of their intensity and cross-reactivity, the antiglycan responses resulting from infection could be a smoke screen to subvert the immune system away from more vulnerable larval peptide epitopes. Their occurrence in humans might explain the long time required for antischistosome immunity to build up after infection.
Subject(s)
Antibodies, Helminth/blood , Lactose/analogs & derivatives , Polysaccharides/immunology , Schistosoma/immunology , Animals , Antibody Formation , Antibody Specificity , Antigens, Helminth/immunology , Cross Reactions , Disaccharides/immunology , Epitopes/immunology , Female , Immunity, Cellular , Immunoglobulin G/blood , Immunoglobulin M/blood , Lactose/immunology , Larva/immunology , Lewis X Antigen/immunology , Male , Oocytes/immunology , Oviposition , Pan troglodytes , Time FactorsABSTRACT
Although protective immunity in C57BL/6 mice induced by a single dose of the radiation-attenuated schistosome vaccine is believed to be mediated by Th1-type immune responses, we here report that in BALB/c mice protection can also depend upon signaling via the interleukin-4 (IL-4) receptor which conventionally governs the development of Th2-type immune responses. We show that in BALB/c mice deficient for the IL-4 receptor alpha chain (IL-4Ralpha(-/-)), which are unresponsive to IL-4 and IL-13, vaccine-induced protection is abrogated compared with that in wild-type (WT) mice. In vaccinated IL-4Ralpha(-/-) mice, IL-12p40 production by cells from the skin exposure site was elevated, although gamma interferon (IFN-gamma) production in draining lymphoid tissues was similar in WT and IL-4Ralpha(-/-) mice. Nevertheless, the effector response in IL-4Ralpha(-/-) mice was Th1 biased with elevated IFN-gamma in the lungs and higher immunoglobulin G2a (IgG2a) and IgG2b titers but negligible quantities of Th2-associated IgG1 and IgE. Interestingly, levels of IL-4 were equivalent in WT and IL-4Ralpha(-/-) mice, indicating that Th2 responses were not dependent upon signaling by IL-4 or IL-13. No differences in the phenotype and composition of the pulmonary effector mechanism that might explain the failure to induce protection in IL-4Ralpha(-/-) mice were detected. However, passive transfer of partial protection to naive IL-4Ralpha(-/-) mice, using serum from vaccinated WT mice, indicates that Th2-associated antibodies such as IgG1 have a role in parasite elimination in BALB/c strain mice and that signaling via IL-4R can be an important factor in the generation of protection.
Subject(s)
Receptors, Interleukin-4/physiology , Schistosomiasis/immunology , Animals , Cytokines/biosynthesis , Female , Immunization, Passive , Immunoglobulin G/biosynthesis , Immunoglobulin G/classification , Interleukin-12/biosynthesis , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Th1 Cells/physiology , Th2 Cells/physiology , VaccinationABSTRACT
A schistosome infection is initiated when the parasite penetrates the skin of a susceptible host. Relatively large quantities of protein are released by transforming cercariae compared to later larval stages. This represents the first parasite material to which the host's immune system is exposed, yet little is known about the proteins which are released during the first few hours post-transformation. We have shown that antiserum raised against such molecules was capable of imparting protection against a schistosome challenge infection upon passive transfer to naïve mice. By screening a cercarial cDNA library with this serum, 38 positive clones were identified. Sequence analysis showed these to represent 8 different molecules which included Schistosoma mansoni 21-7 kDa antigen, calcium-binding-protein and the vaccine candidate glutathione S-transferase (Sm28GST). In addition, 5 clones were isolated, 1 of which had significant homology to many cytochrome C proteins, another with leukocyte elastase inhibitors and 3 which represented novel molecules. Four clones were expressed in a prokaryotic high-level expression vector, sera produced against each purified recombinant protein and used subsequently to probe Western blots and parasite sections. The leukocyte elastase inhibitor homologue and 2 unknowns induced significant proliferation by lymph node cells recovered from mice vaccinated with irradiated cercariae. More strikingly, the 2 novel proteins stimulated very high levels of interferon gamma (IFNgamma) secretion both by lymph node cells and those recovered by broncho-alveolar lavage from the lungs of vaccinated mice. Such results will be discussed in the context of vaccine development.
Subject(s)
Antigens, Helminth/immunology , Schistosoma mansoni/immunology , Amino Acid Sequence , Animals , Antigens, Helminth/genetics , Blotting, Western/veterinary , Cloning, Molecular , Consensus Sequence , Horses , Humans , Immunization, Passive , Leukocyte Elastase/antagonists & inhibitors , Life Cycle Stages , Lymphocyte Activation , Mice , Molecular Sequence Data , Schistosoma mansoni/physiology , SwineABSTRACT
Due to the synergistic effects of IL-12 and IL-18, and to their importance in establishing a Th1 type immune response, we investigated the potential of a combined administration of both cytokines as an adjuvant for recombinant antigens. As a model system, we used a schistosome T cell antigen recently identified in our group. By co-adsorption of this antigen on alum in the presence of IL-12 and IL-18, we demonstrate that IL-18 enhances the effects of IL-12 in inducing an antigen-specific Th1 type CD4(+) T cell response as well as high titres of IgG1, IgG2a, and IgG2b antibodies.
Subject(s)
Adjuvants, Immunologic/administration & dosage , Antigens/administration & dosage , Interleukin-12/administration & dosage , Interleukin-18/administration & dosage , Th1 Cells/drug effects , Th1 Cells/immunology , Animals , Antibodies, Helminth/biosynthesis , Antibodies, Helminth/blood , Antigens, Helminth/administration & dosage , Drug Synergism , Female , Helminth Proteins/administration & dosage , Helminth Proteins/immunology , Immunoglobulin G/biosynthesis , Immunoglobulin G/blood , Mice , Mice, Inbred C57BL , Recombinant Proteins/administration & dosage , Recombinant Proteins/immunology , Schistosoma mansoni/immunologyABSTRACT
C57BL/6 mice exposed to the radiation-attenuated schistosome vaccine exhibit high levels of protective immunity. The cell-mediated pulmonary effector mechanism involves IFN-gamma-producing CD4+ T cells in a focal response around challenge larvae. IFN-gamma can promote production of TNF and can synergize with this cytokine in its actions on responder cells. We have examined whether TNF plays a role in lung phase immunity to schistosomes using mice with a disrupted gene for TNFRI (TNFRI-/-). The most dramatic finding was that the schistosome vaccine elicited no protection whatsoever in these mice. However, this could not be attributed to a lack of responder cells, because more lymphocytes were lavaged from the airways of TNFRI-/- than wild-type mice. Furthermore, CD4+ T cells were equally represented in airway populations from the two groups and produced IFN-gamma upon Ag stimulation in vitro. In contrast, pulmonary macrophage function was defective in TNFRI-/- mice, as indicated by a failure to up-regulate inducible NO synthase mRNA. Histopathological analysis revealed that focal infiltrates were of similar size and cell composition in the two groups but that more parasites were free of foci in the TNFRI-/- mice. These animals had a greatly impaired IgG response to schistosomes, which may explain their lack of residual protection due to Ab in a situation where cell-mediated immunity is disabled. We suggest that the absence of protective immunity could result from a retarded build-up of leukocytes around migrating lung worms and/or a deficit in accessory cell function within a focus, both of which would permit parasite escape.
Subject(s)
Schistosomiasis mansoni/immunology , Schistosomiasis mansoni/prevention & control , Tumor Necrosis Factor-alpha/physiology , Vaccines/immunology , Animals , Antibodies, Helminth/biosynthesis , Antigens, CD/genetics , Antigens, CD/metabolism , Bronchoalveolar Lavage Fluid/immunology , Cell Movement/genetics , Cell Movement/immunology , Cytokines/biosynthesis , Immunity, Active , Immunity, Cellular , Immunization, Secondary , Leukocytes/immunology , Leukocytes/parasitology , Lung/immunology , Lung/parasitology , Macrophages, Alveolar/immunology , Macrophages, Alveolar/parasitology , Mice , Mice, Inbred C57BL , Mice, Knockout , Receptors, Tumor Necrosis Factor/genetics , Receptors, Tumor Necrosis Factor/metabolism , Receptors, Tumor Necrosis Factor, Type I , Schistosoma mansoni/immunology , Schistosoma mansoni/radiation effects , Th1 Cells/immunology , Th1 Cells/metabolism , Th1 Cells/parasitology , Vaccines, Attenuated/immunologyABSTRACT
An in vivo model of pulmonary granuloma formation around embolized schistosome eggs was investigated as an environment in which to analyse a role for interleukin-12 (IL-12) in the differentiation of T-helper 1 (Th1) and Th2 subsets. Specifically, mice deficient for the interferon-gamma receptor (IFN-gammaR-/-) were used to determine the role for IL-12 in the absence of IFN-gamma-mediated signalling. We show that recombinant IL-12 administered to IFN-gammaR-/- mice caused the up-regulation of mRNA for IFN-gamma in lung tissue, and the secretion of abundant IFN-gamma by in vitro-cultured lymph node cells in response to egg antigens. This indicates that IL-12 can act independently of IFN-gamma to induce the development of Th1 cells. Administration of rIL-12 to wild-type mice markedly reduced the secretion of Th2-associated cytokines, IL-4 and IL-5. However, these cytokines were not dramatically reduced in IFN-gammaR-/- mice treated with IL-12. We conclude that inhibition of these cytokines by IL-12 is primarily dependent upon effective IFN-gamma signalling, although abrogation of T-cell derived IL-10 appeared to be dependent upon IL-12. We also show that increases in mRNA for the beta2 subunit of the IL-12 receptor and the p40 subunit of IL-12 after rIL-12 treatment were lower in IFN-gammaR-/- mice, compared to wild-type mice, indicating that their expression was primarily dependent upon IFN-gamma with only a minor role for IL-12.
Subject(s)
Interferon-gamma/immunology , Interleukin-12/immunology , Schistosomiasis mansoni/immunology , Th1 Cells/immunology , Th2 Cells/immunology , Animals , Cell Culture Techniques , Down-Regulation/immunology , Granuloma/immunology , Interferon-gamma/genetics , Interleukin-4/biosynthesis , Interleukin-5/biosynthesis , Mice , Mice, Inbred Strains , RNA, Messenger/genetics , Receptors, Interferon/deficiency , Receptors, Interferon/genetics , Recombinant Proteins/immunology , Reverse Transcriptase Polymerase Chain Reaction , Interferon gamma ReceptorABSTRACT
Lung-stage schistosomula are the target of protective immunity in mice vaccinated with attenuated cercariae of Schistosoma mansoni. Therefore, proteins present at this developmental stage, and in particular those which are secreted, are a potential source of novel vaccine candidates. However, little information is available about such molecules. Here we describe the cDNA clones identified by screening expression libraries with serum raised against proteins released by lung-stage schistosomula. In total, 11 different cDNA species were identified, 6 of which have been described previously in S. mansoni; these included fructose 1,6-bisphosphate aldolase and Sm21.7 which together accounted for two-thirds of all positive clones. Of the 5 newly described schistosome genes, 1 cDNA had a high degree of homology to the s5a subunit of 26S proteasomes, most significant being with the human protein. The remaining 4 clones showed no significant homologies to any genes sequenced previously. Fructose 1,6-bisphosphate aldolase, Sm21.7, the proteasome homologue and 1 unknown clone (A26) have been expressed in a bacterial expression system and serum produced against each recombinant protein. Immunolocalization showed fructose 1,6-bisphosphate aldolase, Sm21.7 and the proteasome homologue to be most abundant in muscle cells whilst clone A26 was distributed throughout many tissues, but was most abundant in the tegument. Analysis of the cellular immune responses of vaccinated mice showed 3 of the 4 expressed clones to be highly immunogenic, inducing the secretion of large quantities of the Th1-type cytokine interferon gamma.
Subject(s)
Antigens, Helminth/genetics , Schistosoma mansoni/immunology , Amino Acid Sequence , Animals , Antigens, Helminth/biosynthesis , Base Sequence , Biomphalaria/parasitology , Blotting, Western , DNA, Complementary/genetics , DNA, Helminth/genetics , Gene Library , Humans , Mice , Molecular Sequence Data , Rabbits , Schistosoma mansoni/genetics , Schistosoma mansoni/metabolism , Sequence AlignmentABSTRACT
Radiation-attenuated cercariae of Schistosoma mansoni elicit consistently high levels of protective immunity in mice. The cell-mediated pulmonary effector mechanisms have been well characterized but the role of B cells and antibodies remains ill defined. We have compared the immune responses of B-cell-deficient (muMT) mice and their wild-type (WT) counterparts following exposure to the attenuated vaccine. Both groups mounted a T helper type 1 (Th1)-biased response in the skin-draining lymph nodes after vaccination. Interferon-gamma was the dominant cytokine secreted by airway leucocytes after challenge in both muMT and WT mice, but there was a somewhat greater Th2 component in the former animals. The cellular infiltrates observed in the airways, and the pulmonary effector foci, were of similar composition in the two groups although some large foci were present in the muMT mice. There was a marked dichotomy in the protection induced in muMT animals by a single vaccination, with two-thirds showing levels similar to their WT counterparts, demonstrating that cell-mediated mechanisms alone can provide adequate protection. The remaining muMT mice had a mean worm burden identical to that of their challenge controls. A possible explanation is that a proportion of the muMT animals have a genetic defect closely associated with the mu-heavy-chain locus on chromosome 12, which affects their ability to mount a protective cell-mediated response. Three vaccinations enhanced the immunity of WT animals, most likely by augmenting antibody-mediated mechanisms. In contrast, no enhancement was seen in muMT mice, suggesting that the cell-mediated response is not boosted by multiple exposures to attenuated larvae.